PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies

Marcelle Silva-Abreu,1,2 Ana Cristina Calpena,1,2 Pol Andrés-Benito,3,4 Ester Aso,3,4 Ignacio A Romero,5 David Roig-Carles,5 Radka Gromnicova,5 Marta Espina,1,2 Isidre Ferrer,3,4 María Luisa García,1,2 David Male5 1Department of Pharmacy, Pharmaceutical Technology a...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D
Format: article
Langue:EN
Publié: Dove Medical Press 2018
Sujets:
Nanoparticle
Alzheimer’s disease
Blood brain barrier
Brain endothelium
Pioglitazone
APP/PS1 transgenic mouse.
Medicine (General)
R5-920
Accès en ligne:https://doaj.org/article/2417f5fa9d024b44a02f84dea736322c
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/2417f5fa9d024b44a02f84dea736322c

Documents similaires